Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Somayeh Yazdanparast"'
Autor:
Somayeh Yazdanparast, Davood Bashash, Amirsalar Nikkhah Bahrami, Mohammad Ghorbani, Mehrdad Izadirad, Mehdi Bakhtiyaridovvombaygi, Ahmad Gharehbaghian
Publikováno v:
Iranian Journal of Basic Medical Sciences, Vol 27, Iss 7, Pp 801-812 (2024)
Objective(s): Until recently, a conventional chemotherapy regimen for Acute lymphoblastic leukemia (ALL) is considered an efficient therapeutic method in children. However, suboptimal long-term survival rates in adults, disease relapse, and drug-indu
Externí odkaz:
https://doaj.org/article/baed8d007dc84414b5017077ef41690e
Autor:
Mehdi Bakhtiyaridovvombaygi, Somayeh Yazdanparast, Setare Kheyrandish, Seyed Mehrab Safdari, Fateme Amiri Samani, Mahsa Sohani, Akram Sadat Jaafarian, Fateme Damirchiloo, Amirhossein Izadpanah, Sahar Parkhideh, Fatemeh Mikanik, Elham Roshandel, Abbas Hajifathali, Ahmad Gharehbaghian
Publikováno v:
Biomarker Research, Vol 12, Iss 1, Pp 1-44 (2024)
Abstract Non-Hodgkin lymphomas (NHLs) are heterogeneous and are among the most common hematological malignancies worldwide. Despite the advances in the treatment of patients with NHLs, relapse or resistance to treatment is anticipated in several pati
Externí odkaz:
https://doaj.org/article/3a0a338346264057a589263ac2d40f6e
Autor:
Mehdi Bakhtiyaridovvombaygi, Somayeh Yazdanparast, Fatemeh Mikanik, Amirhossein Izadpanah, Sahar Parkhideh, Amin Shahbaz ghasabeh, Elham Roshandel, Abbas Hajifathali, Ahmad Gharehbaghian
Publikováno v:
Biomedicine & Pharmacotherapy, Vol 168, Iss , Pp 115718- (2023)
Acute myeloid leukemia (AML) is a heterogeneous disease developed from the malignant expansion of myeloid precursor cells in the bone marrow and peripheral blood. The implementation of intensive chemotherapy and hematopoietic stem cell transplantatio
Externí odkaz:
https://doaj.org/article/bbe3c09c1c1e4103abc83eb43fc2df61
Autor:
Somayeh Yazdanparast, Zoufang Huang, Shayan Keramat, Mehrdad Izadirad, Yi-Dong Li, Letao Bo, Ahmad Gharehbaghian, Zhe-Sheng Chen
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundDiffuse large B-cell lymphoma (DLBCL) is a heterogeneous neoplasm and is characterized as the most common subtype of non-Hodgkin lymphoma (NHL). Despite 60–70% of all patients being cured with R-CHOP therapeutic regimen (Cyclophosphamide,
Externí odkaz:
https://doaj.org/article/e2acccb6f2de42f1b81ce21cf5afa0df